Table 4:

Relative risk of specified outcomes for iodixanol versus LOCM

UnadjustedAdjusted
RR99% CIRR99% CI
mRS 0–21.16750.56062.43141.20020.61232.3528
mTICI 2b/31.25350.72912.15491.28290.78882.0864
AICH0.70510.32161.54570.65960.30511.4260
SICH0.73120.10485.1038NA
Mortality0.75930.26832.14860.75380.27672.0537
  • Note:—RR indicates relative risk; AICH, asymptomatic ICH.